Diclofenac shouldn’t be prescribed to people with heart problems, drug agency saysBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4285 (Published 02 July 2013) Cite this as: BMJ 2013;347:f4285
- Jacqui Wise
Diclofenac should not be prescribed to patients with serious underlying heart conditions because of a small increased risk of heart attack and stroke, the UK Medicines and Healthcare Products Regulatory Agency has warned.1
The advice comes after a recent meta-analysis found that the arterial thrombotic risk with diclofenac was similar to that with the selective cyclo-oxygenase-2 (COX-2) inhibitors.2 The study found that, in comparison with placebo, the risk of major vascular events was increased by about a third by a COX-2 inhibitor (rate ratio 1.4 (95% confidence interval …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial